Company · CIK 0001722964 · SIC 2834 — Pharmaceutical Preparations
Y-mAbs Therapeutics, Inc. · YMAB
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2018 PForm 4 → | Sep 26, 4:16 pm EDT | Ashu TyagiDirector | 430,174 | $16.00 | $6,882,784 | 1,392,740 | +44.7% | plan? |
| Sep 25, 2018 PForm 4 → | Sep 25, 4:37 pm EDT | Moller San Pedro Claus JuanChief Executive Officer, Director | 31,250 | $16.00 | $500,000 | 872,928 | +3.71% | plan? |
| Sep 21, 2018 PForm 4 → | Sep 25, 8:41 pm EDT | James HealyDirector | 500,000 | $16.00 | $8,000,000 | 2,104,278 | +31.2% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2018 AForm 4 → | Dec 13, 4:13 pm EST | Moller San Pedro Claus JuanChief Executive Officer, Director | 211,500 | — | — | 211,500 | — | |
| Dec 11, 2018 AForm 4 → | Dec 13, 4:12 pm EST | Joris WilmsSr. VP and COO | 20,000 | — | — | 20,000 | — | |
| Dec 11, 2018 AForm 4 → | Dec 13, 4:12 pm EST | Bo KruseEVP, CFO, Secy & Treas., Director | 107,500 | — | — | 107,500 | — | |
| Dec 11, 2018 AForm 4 → | Dec 13, 4:11 pm EST | Torben Lund-HansenSr VP & Head of Technical Oper | 20,000 | — | — | 20,000 | — | |
| Dec 11, 2018 AForm 4 → | Dec 13, 4:11 pm EST | Thomas GadPresident and Chairman, Director | 107,500 | — | — | 107,500 | — | |
| Dec 11, 2018 AForm 4 → | Dec 13, 4:11 pm EST | Steen LisbySr VP & CMO | 20,000 | — | — | 20,000 | — |